Nicoletta Loggia's most recent trade in Candel Therapeutics Inc was a trade of 2,141 Common Stock done at an average price of $4.7 . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Nicoletta Loggia | Director | Grant, award, or other acquisition of securities at price $ 4.67 per share. | 25 Jun 2025 | 2,141 | 2,141 | - | 4.7 | 9,998 | Common Stock |
| Candel Therapeutics Inc | Nicoletta Loggia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Nicoletta Loggia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Nicoletta Loggia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 28,480 | 28,480 | - | - | Stock Option (Right to Buy) |